homepage logo

Argenta to buy Scottish plant from Elanco

By Staff | Feb 13, 2017

FORT?DODGE – The two international animal pharmaceutical companies with a presence in Fort Dodge have entered an agreement for the purchase of a facility in Scotland.

Argenta, the parent company of AML Riverside LLC in Fort Dodge, is buying the plant from Elanco Animal Health, which recently took over the former Boehringer Ingelheim Vetmedica Inc. site in Fort Dodge.

The transaction was announced Thursday by Argenta, which is based in New Zealand.

The deal is not expected to impact the local operations of either company, according to Dennis Plautz, the chief executive officer of the Greater Fort Dodge Growth Alliance.

He said he views the transaction as a positive development that will build up the existing partnerships the two companies now have.

“From what I know, this further cements the relationships between Argenta and Elanco,” he said.

The plant at the heart of the deal is an 80,000-square-foot facility in Dundee, Scotland, that employs 118 people.

The purchase price was not disclosed. The deal is expected to close in the second quarter of this year.

The Scottish plant will be Argenta’s third manufacturing facility. The company has one in New Zealand in addition to the Fort Dodge site.

The AML Riverside LLC plant opened in January 2016.

Please Enter Your Facebook App ID. Required for FB Comments. Click here for FB Comments Settings page